Additional analyses of Cost-effectiveness of Domiciliary High Flow Nasal Cannula treatment in COPD patients with chronic respiratory failure

Date made available	6 May 2021
Publisher	VBN
Date of data production	4 May 2021

• DOI

  10.5278/bf9d4464-c2e7-4c58-8c23-107fd93b7224

Access Dataset

• Additional_analyses_of_Cost_effectiveness_of_Domiciliary_High_Flow_Nasal_Cannula_treatment_in_COPD_patients.pdf

  File: application/pdf, 465 KB

  Type: Audiovisual

Cite this

• DataSetCite

Sørensen, S. S. (Creator) (6 May 2021). Additional analyses of Cost-effectiveness of Domiciliary High Flow Nasal Cannula treatment in COPD patients with chronic respiratory failure. VBN. Additional_analyses_of_Cost_effectiveness_of_Domiciliary_High_Flow_Nasal_Cannula_treatment_in_COPD_patients(.pdf). 10.5278/bf9d4464-c2e7-4c58-8c23-107fd93b7224